| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
INSERM U-344, Endocrinologie Moléculaire, Faculté de Médecine Necker (P.C.-L., V.G., B.B., N.B., P.A.K.), 75730 Paris Cedex 15, France; Cancer Research Program, Garvan Institute of Medical Research (C.O.), Darlinghurst, New South Wales 2010, Sydney, Australia; Hoechst Marion Roussel, Inc.-France (L.L., M.G.-K., R.B.), 93235 Romainville, France; the Division of Clinical Pathophysiology, World Health Organization Collaborating Center for Osteoporosis and Bone Diseases, Department of Internal Medicine, University Hospital (P.A.), Geneva, Switzerland; Service Anatomo-Pathologie, Hôpital Necker-Enfants Malades, Université René Descartes Paris V (D.D.), 75015 Paris, France; and the Departments of Cell Biology and Orthopedics, Yale University School of Medicine (M.A., R.B.), New Haven, Connecticut 06510
Address all correspondence and requests for reprints to: Dr. Paul A. Kelly, INSERM U-344, Endocrinologie Moléculaire, Faculté de Médecine Necker, 156 rue de Vaugirard, 75730 Paris Cedex 15, France. E-mail: kelly{at}necker.fr
Bone development is a multistep process that includes patterning of skeletal elements, commitment of hematopoietic and/or mesenchymental cells to chondrogenic and osteogenic lineages, and further differentiation into three specialized cell types: chondrocytes in cartilage and osteoblasts and osteoclasts in bone. Although PRL has a multitude of biological actions in addition to its role in the mammary gland, very little is known about its effect on bone. Mice carrying a germline null mutation for the PRL receptor gene have been produced in our laboratory and used to study the role of PRL in bone formation. In -/- embryos, we observed an alteration in bone development of calvaria. In adults, histomorphometric analysis showed that the absence of PRL receptors leads to a decrease in bone formation rate using double calcein labeling and a reduction of bone mineral density, measured by dual energy x-ray absorptiometry. In addition, serum estradiol, progesterone, testosterone, and PTH levels were analyzed. We also established that osteoblasts, but not osteoclasts, express PRL receptors. This suggests that an effect of PRL on osteoblasts could be required for normal bone formation and maintenance of bone mass. Thus, the PRL receptor knockout mouse model provides a new tool to investigate the involvement of PRL in bone metabolism.
This article has been cited by other articles:
![]() |
M K. Javaid and R. I. Holt Understanding osteoporosis J Psychopharmacol, March 1, 2008; 22(2_suppl): 38 - 45. [Abstract] [PDF] |
||||
![]() |
M. J. LeBaron, T. J. Ahonen, M. T. Nevalainen, and H. Rui In Vivo Response-Based Identification of Direct Hormone Target Cell Populations Using High-Density Tissue Arrays Endocrinology, March 1, 2007; 148(3): 989 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Charoenphandhu, K. Tudpor, K. Thongchote, W. Saengamnart, S. Puntheeranurak, and N. Krishnamra High-calcium diet modulates effects of long-term prolactin exposure on the cortical bone calcium content in ovariectomized rats Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E443 - E452. [Abstract] [Full Text] [PDF] |
||||
![]() |
A J Craven, A J Nixon, M G Ashby, C J Ormandy, K Blazek, R J Wilkins, and A J Pearson Prolactin delays hair regrowth in mice. J. Endocrinol., November 1, 2006; 191(2): 415 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Zermeno, J Guzman-Morales, Y Macotela, G Nava, F Lopez-Barrera, J B Kouri, C Lavalle, G M. de la Escalera, and C Clapp Prolactin inhibits the apoptosis of chondrocytes induced by serum starvation. J. Endocrinol., May 1, 2006; 189(2): R1 - R8. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Shur, R. Solomon, and D. Benayahu Dynamic Interactions of Chromatin-Related Mesenchymal Modulator, a Chromodomain Helicase-DNA-Binding Protein, with Promoters in Osteoprogenitors. Stem Cells, May 1, 2006; 24(5): 1288 - 1293. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kedzia, L. Lacroix, N. Ameur, T. Ragot, P. A. Kelly, B. Caillou, and N. Binart Medullary Thyroid Carcinoma Arises in the Absence of Prolactin Signaling Cancer Res., September 15, 2005; 65(18): 8497 - 8503. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Miller, B. L. Anderson, and B. M. Bowman Weaning Initiates a Rapid and Powerful Anabolic Phase in the Rat Maternal Skeleton Biol Reprod, July 1, 2005; 73(1): 156 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fleenor, J. Oden, P. A. Kelly, S. Mohan, S. Alliouachene, M. Pende, S. Wentz, J. Kerr, and M. Freemark Roles of the Lactogens and Somatogens in Perinatal and Postnatal Metabolism and Growth: Studies of a Novel Mouse Model Combining Lactogen Resistance and Growth Hormone Deficiency Endocrinology, January 1, 2005; 146(1): 103 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. VanHouten and J. J. Wysolmerski Low Estrogen and High Parathyroid Hormone-Related Peptide Levels Contribute to Accelerated Bone Resorption and Bone Loss in Lactating Mice Endocrinology, December 1, 2003; 144(12): 5521 - 5529. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Yarram, M. J. Perry, T. J. Christopher, K. Westby, N. L. Brown, T. Lamminen, S. B. Rulli, F.-P. Zhang, I. Huhtaniemi, J. R. Sandy, et al. Luteinizing Hormone Receptor Knockout (LuRKO) Mice and Transgenic Human Chorionic Gonadotropin (hCG)-Overexpressing Mice (hCG {alpha}{beta}+) Have Bone Phenotypes Endocrinology, August 1, 2003; 144(8): 3555 - 3564. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Robertson, J. Harris, M. J. Naylor, S. R. Oakes, J. Kindblom, K. Dillner, H. Wennbo, J. Tornell, P. A. Kelly, J. Green, et al. Prostate Development and Carcinogenesis in Prolactin Receptor Knockout Mice Endocrinology, July 1, 2003; 144(7): 3196 - 3205. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Foitzik, K. Krause, A. J. Nixon, C. A. Ford, U. Ohnemus, A. J. Pearson, and R. Paus Prolactin and Its Receptor Are Expressed in Murine Hair Follicle Epithelium, Show Hair Cycle-Dependent Expression, and Induce Catagen Am. J. Pathol., May 1, 2003; 162(5): 1611 - 1621. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Ormandy, M. Naylor, J. Harris, F. Robertson, N. D. Horseman, G. J. Lindeman, J. Visvader, and P. A. Kelly Investigation of the Transcriptional Changes Underlying Functional Defects in the Mammary Glands of Prolactin Receptor Knockout Mice Recent Prog. Horm. Res., January 1, 2003; 58(1): 297 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Allan, E. Tonner, M. C. Barber, M. T. Travers, J. H. Shand, R. G. Vernon, P. A. Kelly, N. Binart, and D. J. Flint Growth Hormone, Acting in Part through the Insulin-Like Growth Factor Axis, Rescues Developmental, But Not Metabolic, Activity in the Mammary Gland of Mice Expressing a Single Allele of the Prolactin Receptor Endocrinology, November 1, 2002; 143(11): 4310 - 4319. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Cruz-Soto, M. D. Scheiber, K. A. Gregerson, G. P. Boivin, and N. D. Horseman Pituitary Tumorigenesis in Prolactin Gene-Disrupted Mice Endocrinology, November 1, 2002; 143(11): 4429 - 4436. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Gevers, N. Loveridge, and I. C. A. F. Robinson Bone Marrow Adipocytes: A Neglected Target Tissue for Growth Hormone Endocrinology, October 1, 2002; 143(10): 4065 - 4073. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Freemark, I. Avril, D. Fleenor, P. Driscoll, A. Petro, E. Opara, W. Kendall, J. Oden, S. Bridges, N. Binart, et al. Targeted Deletion of the PRL Receptor: Effects on Islet Development, Insulin Production, and Glucose Tolerance Endocrinology, April 1, 2002; 143(4): 1378 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-y. Yu-Lee Stimulation of interferon regulatory factor-1 by prolactin Lupus, October 1, 2001; 10(10): 691 - 699. [Abstract] [PDF] |
||||
![]() |
L. Welniak, S. Richards, and W. Murphy Effects of prolactin on hematopoiesis Lupus, October 1, 2001; 10(10): 700 - 705. [Abstract] [PDF] |
||||
![]() |
S. Bernichtein, S. Kinet, S. Jeay, M. Llovera, D. Madern, J. A. Martial, P. A. Kelly, and V. Goffin S179D-Human PRL, a Pseudophosphorylated Human PRL Analog, Is an Agonist and Not an Antagonist Endocrinology, September 1, 2001; 142(9): 3950 - 3963. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Craven, C. J. Ormandy, F. G. Robertson, R. J. Wilkins, P. A. Kelly, A. J. Nixon, and A. J. Pearson Prolactin Signaling Influences the Timing Mechanism of the Hair Follicle: Analysis of Hair Growth Cycles in Prolactin Receptor Knockout Mice Endocrinology, June 1, 2001; 142(6): 2533 - 2539. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Freemark, D. Fleenor, P. Driscoll, N. Binart, and P. A. Kelly Body Weight and Fat Deposition in Prolactin Receptor-Deficient Mice Endocrinology, February 1, 2001; 142(2): 532 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. McClellan, F. G. Robertson, J. Kindblom, H. Wennbo, J. Törnell, B. Bouchard, P. A. Kelly, and C. J. Ormandy Investigation of the Role of Prolactin in the Development and Function of the Lacrimal and Harderian Glands Using Genetically Modified Mice Invest. Ophthalmol. Vis. Sci., January 1, 2001; 42(1): 23 - 30. [Abstract] [Full Text] |
||||
![]() |
D. Coss, L. Yang, C. B. Kuo, X. Xu, R. A. Luben, and A. M. Walker Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat Am J Physiol Endocrinol Metab, December 1, 2000; 279(6): E1216 - E1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ling, G. Hellgren, M. Gebre-Medhin, K. Dillner, H. Wennbo, B. Carlsson, and H. Billig Prolactin (PRL) Receptor Gene Expression in Mouse Adipose Tissue: Increases during Lactation and in PRL-Transgenic Mice Endocrinology, October 1, 2000; 141(10): 3564 - 3572. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Binart, C. Helloco, C. J. Ormandy, J. Barra, P. Clement-Lacroix, N. Baran, and P. A. Kelly Rescue of Preimplantatory Egg Development and Embryo Implantation in Prolactin Receptor-Deficient Mice after Progesterone Administration Endocrinology, July 1, 2000; 141(7): 2691 - 2697. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bouchard, C. J. Ormandy, J. P. Di Santo, and P. A. Kelly Immune System Development and Function in Prolactin Receptor-Deficient Mice J. Immunol., July 15, 1999; 163(2): 576 - 582. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Freemark Editorial: The Fetal Adrenal and the Maturation of the Growth Hormone and Prolactin Axes Endocrinology, May 1, 1999; 140(5): 1963 - 1965. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |